Advanced search
Publication Cover
Emerging Microbes & Infections Volume 12, 2023 - Issue 1
Submit an article Journal homepage
2,653
Views
1
CrossRef citations to date
0
Altmetric
Influenza infections

Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence

Ning Maa National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;b The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Zhi-Wu Xiaa National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;c School of Animal Science and Technology, School of Animal Medicine, Huazhong Agricultural University, Wuhan, People’s Republic of ChinaView further author information
,
Zhe-Gang Zhanga National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;b The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Xuan-Xuan Niana National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;b The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Xue-Dan Lia National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;b The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Zheng Gonga National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;b The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Guo-Mei Zhanga National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;b The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Yang Lea National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;b The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Rong Zhoua National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;b The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Jia-You Zhanga National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;b The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Xiao-Ming Yanga National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;d China National Biotec Group Company Limited, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2202278 | Received 22 Jan 2023, Accepted 07 Apr 2023, Published online: 01 May 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.